Drug profile · INN
ipodate calcium
ORAGRAFIN CALCIUM
ipodate calcium (ORAGRAFIN CALCIUM) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Drug details — ipodate calcium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
ipodate calcium (ORAGRAFIN CALCIUM) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is ipodate calcium?
ipodate calcium (ORAGRAFIN CALCIUM) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ipodate calcium?
ORAGRAFIN CALCIUM is a marketed brand name for ipodate calcium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ipodate calcium?
ipodate calcium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.